Azilsartan, but not Candesartan Improves Left Ventricular Diastolic Function in Patients with Hypertension and Heart Failure

Braunwald, 2000, Congestive heart failure: fifty years of progress, Circulation, 102, 14 Torre-Amione, 1999, The syndrome of heart failure: emerging concepts in the understanding of its pathogenesis and treatment, Curr Opin Cardiol, 14, 193, 10.1097/00001573-199905000-00001 Packer, 1988, Neurohormonal interactions and adaptations in congestive heart failure, Circulation, 77, 721, 10.1161/01.CIR.77.4.721 Wachter, 2014, Diagnosis of heart failure with preserved ejection fraction, Heart Fail Clin, 10, 399, 10.1016/j.hfc.2014.04.010 Komajda, 2014, Heart failure with preserved ejection fraction: a clinical dilemma, Eur Heart J, 35, 1022, 10.1093/eurheartj/ehu067 Elzinga, 1973, Pressure and flow generated by the left ventricle against different impedances, Circ Res, 32, 178, 10.1161/01.RES.32.2.178 Hori, 1984, Ejection timing as a major determinant of left ventricular relaxation rate in isolated perfused canine heart, Circ Res, 55, 31, 10.1161/01.RES.55.1.31 Hori, 1985, Loading sequence is a major determinant of afterload-dependent relaxation in intact canine heart, Am J Physiol, 249, H747 Shapiro, 2007, Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model, Hypertension, 50, 503, 10.1161/HYPERTENSIONAHA.107.090092 White, 2011, Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension, Hypertension, 57, 413, 10.1161/HYPERTENSIONAHA.110.163402 Lang, 2005, J Am Soc Echocardiogr, 18, 1440, 10.1016/j.echo.2005.10.005 Redfield, 2003, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic, JAMA, 289, 194, 10.1001/jama.289.2.194 Devereux, 1986, Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings, Am J Cardiol, 57, 450, 10.1016/0002-9149(86)90771-X Teichholz, 1976, Problems in echocardiographic volume determinations: echocardiographic–angiographic correlations in the presence of absence of asynergy, Am J Cardiol, 37, 7, 10.1016/0002-9149(76)90491-4 Dokainish, 2004, Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters, Circulation, 109, 2432, 10.1161/01.CIR.0000127882.58426.7A Chrysant, 2009, Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum, Clin Ther, 30, 2181 Angiotensin, 2005, II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option, Prescrire Int, 14, 180 Khawaja, 2011, An overview of candesartan in clinical practice, Expert Rev Cardiovasc Ther, 9, 975, 10.1586/erc.11.90 Skvortsov, 2006, Kardiologiia, 46, 33 Massie, 2008, Irbesartan in patients with heart failure and preserved ejection fraction, N Engl J Med, 359, 2456, 10.1056/NEJMoa0805450 Yusuf, 2003, Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial, Lancet, 362, 777, 10.1016/S0140-6736(03)14285-7 Goebel, 2014, Early diastolic strain rate predicts response to heart failure therapy in patients with dilated cardiomyopathy, Int J Cardiovasc Imaging, 30, 505, 10.1007/s10554-014-0361-8 Baker, 2011, Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension, Ann Pharmacother, 45, 1506, 10.1345/aph.1Q468 Ishii, 2014, Examination of the effect of changing to azilsartan from candesartan in renal transplant patients, Transplant Proc, 46, 492, 10.1016/j.transproceed.2013.11.018 Chung, 2006, Diastolic ventricular-vascular stiffness and relaxation relation: elucidation of coupling via pressure phase plane-derived indexes, Am J Physiol Heart Circ Physiol, 291, H2415, 10.1152/ajpheart.00257.2006 Andreadis, 2010, Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness, Int Angiol, 29, 266